QQQJ
Invesco NASDAQ Next Gen 100 ETF
QQQJ tracks a modified market-cap-weighted, narrow index of 100 non-financial stocks that are next-eligible for inclusion in the NASDAQ-100 Index.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 766.2 M
ASSETS UNDER MGMT
15 bp
EXPENSES
Fund Basics
| Inception date | Oct 13, 2020 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Quarterly |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| ALNYLAM PHARMACEUTICALS INC | 3.2 % |
| SEAGATE TECHNOLOGY HOLDINGS PLC | 2.9 % |
| WESTERN DIGITAL CORP | 2.4 % |
| MONOLITHIC POWER SYSTEMS INC | 2.3 % |
| EBAY INC | 2.2 % |
| ASTERA LABS INC | 1.8 % |
| INSMED INC | 1.8 % |
| SUPER MICRO COMPUTER, INC. | 1.6 % |
| UNITED CONTINENTAL HOLDINGS | 1.6 % |
| TRACTOR SUPPLY COMPANY | 1.6 % |
Constituent Breakdown
| Number of holdings | 99 |
| Herfindahl-Hirschman Index | 122 |
| Wgt avg mkt cap (mns) | $23,962 |
| Large cap (>$10bn) | 83.9% |
| Mid cap ($2-10bn) | 8.7% |
| Small cap (<$2bn) | 0.1% |
| Developed mkts. | 89.1% |
| Emerging mkts. | 3.6% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 74.3 % |
 |
ISRAEL | 4.7 % |
 |
IRELAND | 4.2 % |
 |
CHINA | 3.6 % |
 |
SINGAPORE | 2.4 % |
 |
NETHERLANDS | 1.3 % |
 |
SWITZERLAND | 0.9 % |
 |
FRANCE | 0.7 % |
 |
GERMANY | 0.6 % |
Historical Performance
Standardized Performance (as of 03/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | -1.7% | 24.8% | 11.9% | 12.4% | 2.6% | -- | -- | 5.7% |
| Dividend Yield | 0.2% | 1.2% | 0.9% | 0.9% | 0.9% | -- | -- | 0.8% |
| Total Returns | -1.6% | 26.0% | 12.8% | 13.3% | 3.5% | -- | -- | 6.5% | Ann. Volatility | 23.1% | 22.4% | 19.7% | 18.3% | 22.0% | -- | -- | 22.1% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 1.07 | 82% |
| MSCI EAFE | 1.00 | 62% |
| MSCI Emg Mkts | 0.88 | 62% |
Liquidity Measures
| Avg. volume (000) | 160 |
| ADV traded (mns) | $6 |
| Turnover | 0.8% |
| Avg. Bid/Ask (% of price) | 0.06% |
Technical Indicators
| 30d moving avg. (EMA) | $37.16 |
| Relative strength (RSI) | 54 |
| MACD/Signal | 0.13/-0.17 |
| Bollinger Bands (Upper/Lower) | $38.57/$34.99 |
| Short interest (% of AUM) | 0.7% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. QQQJ |
Expenses vs. QQQJ |
ALTAR Score™ vs. QQQJ |
|---|---|---|---|---|
| QQJG | Invesco ESG NASDAQ Next Gen 100 ETF | 77.3% | +5 bp | +0.4% |
| RSPT | Invesco S&P 500 Equal Weight Technology ETF | 18.2% | +25 bp | +0.3% |
| FLQM | Franklin U.S. Mid Cap Multifactor Index ETF | 17.9% | +15 bp | +3.7% |
| TMFX | Motley Fool Next Index ETF | 17.0% | +35 bp | -1.3% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 15.8% | +4 bp | -4.6% |
| FMDE | Fidelity Enhanced Mid Cap ETF | 15.2% | +8 bp | +1.5% |
| AVMC | Avantis U.S. Mid Cap Equity ETF | 14.8% | +3 bp | +1.9% |
| IBB | iShares Biotechnology ETF | 14.7% | +30 bp | -5.5% |
| JHMM | John Hancock Multifactor Mid Cap ETF | 14.7% | +27 bp | +1.3% |
| SPHB | Invesco S&P 500 High Beta ETF | 14.2% | +10 bp | -0.5% |
Risk and Returns: QQQJ vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 4/15/2026
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Historical Valuation Trends Sample data. Subscribe for access.
SHOWING:
Price-to-Earnings
Price-to-Earnings
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
4.9%
ALTAR SCORE™
37th
PERCENTILE
UNDERWEIGHT
ETFRC RATING
There are 1,201 funds in the US Equity category with an average
ALTAR Score™ of 5.5% and a standard deviation
of 2.1%. QQQJ's ALTAR Score™ is approximately -0.3 standard
deviations above the category average. This places QQQJ in the 37th percentile
among funds in the category.
Sell-Side Consensus
$49.68
PRICE TARGET
+24.5%
UPSIDE